WINTON GROUP Ltd Buys New Position in AtriCure, Inc. $ATRC
Winton Group Ltd purchased 35,800 shares of medical device maker AtriCure during the second quarter, according to an SEC filing.
Winton Group Ltd acquired a new position in shares of AtriCure, Inc. (NASDAQ:ATRC) during the second quarter, according to the firm's most recent Form 13F filing with the Securities and Exchange Commission.[1][2]
According to the regulatory disclosure, the institutional investor purchased 35,800 shares of the medical device company during the period.[1][2]



